Reaction
Right Ventricular Hypertrophy reporting signals
As of the last recalculation, Right Ventricular Hypertrophy appears in 899 FAERS reports alongside 25 co-occurring drug terms. The strongest observed disproportionality signal is THEOPHYLLINE ANHYDROUS (PRR 182.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Theophylline Anhydrous | 88 | 182.1 | 183.4 |
| Theophylline | 79 | 174.4 | 175.6 |
| Tamsulosin Hydrochloride | 65 | 79.4 | 79.7 |
| Fluticasone Furoate And Vilanterol Trifenatate | 73 | 51.1 | 51.2 |
| Finasteride | 92 | 39.2 | 39.3 |
| Olmesartan Medoxomil | 48 | 32.6 | 32.6 |
| Apixaban | 84 | 32.0 | 32.0 |
| Indomethacin | 14 | 24.8 | 24.9 |
| Sildenafil Powder, | 36 | 24.4 | 24.4 |
| Ampicillin | 8 | 22.6 | 22.6 |
| Ampicillin Sodium | 8 | 22.6 | 22.6 |
| Paroxetine Hydrochloride | 80 | 22.2 | 22.3 |
| Montelukast Sodium | 96 | 20.3 | 20.3 |
| Tiotropium Bromide | 97 | 18.3 | 18.3 |
| Sildenafil | 43 | 18.0 | 18.0 |
| Bisoprolol Fumarate | 95 | 18.0 | 18.0 |
| Bosentan | 37 | 17.7 | 17.7 |
| Montelukast | 59 | 17.3 | 17.4 |
| Selexipag | 16 | 14.6 | 14.6 |
| Sevoflurane | 5 | 14.0 | 14.0 |
| Tafamidis | 7 | 13.9 | 13.9 |
| Sildenafil Citrate | 59 | 11.4 | 11.4 |
| Rocuronium Bromide | 5 | 9.9 | 9.9 |
| Diclofenac Potassium, Film Coated | 3 | 8.3 | 8.3 |
| Diclofenac Potassium Tablets | 3 | 8.3 | 8.3 |